« Previous
Next »
Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 4
, Pages 386-391
, July 2008
Phospholipase-C gamma-1 (PLCγ-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cells
References
- . Phospholipase C-γ1 in tumor progression. Clin Exp Metast. 2003;20:285–290
- . Inositol phosphates and cell signalling. Nature. 1989;21:197–205
- . Secretagogue-responsive and -unresponsive pools of phosphatidylinositol in pancreatic islets. Arch Biochem Biophys. 1986;245:411–416
- . Phospholipase C-γ1 is required for the induction of immediate early genes by platelet-derived growth factor. J Biol Chem. 2001;23:8627–8630276
- Phospholipase C-γ-1 is a physiological guanine nucleotide exchange factor for the nuclear GTPase PIKE. Nature. 2002;415:541–544
- Hepatocyte growth factor, its receptor, and their potential value in cancer therapies. Crit Rev Oncol Hematol. 2005;53:35–69
- Tyrosine phosphorylation of phospholipase C-γ in C-met/HGF receptor-stimulated hepatocytes: Comparison with HepG2 hepatocarcinoma cells. Biochem Biophys Res Commun. 1993;190:842–848
- . Tumor invasion: Role of growth factor-induced cell motility. Adv Cancer Res. 2000;78:31–101
- PLCγ contributes to metastasis of in situ-occurring mammary and prostate tumors. Oncogene. 2007;26:3020–3026
- . Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acid Res. 2003;31:3406–3415
- Suppression of invasiveness and cellular motility of breast cancer cells by a hammerhead ribozyme encoding cMET antisense. Clin Cancer Res. 2001;7:2555–2562
- Retroviral hammerhead transgene to c-MET and HGF/SF inhibited growth of breast tumor induced by fibroblasts. Clin Cancer Res. 2003;9:4274–4281
- Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression. J Natl Cancer Inst. 1999;91:1548–1556
- . Com-1/P8 in oestrogen regulated growth of breast cancer cells, the ER-β connect. Biochem Biophys Res Commun. 2005;330:253-26
- Targeting the HGF/SF receptor c-Met using a Hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells. The prostate. 2004;60:317–324
- . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–159
- . Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: A key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin Cancer Res. 2001;7:3289–3297
- Growth and angiogenesis of human breast cancer in a nude mouse tumor model is reduced by NK4, a HGF/SF antagonist. Carcinogenesis. 2003;24:1317–1323
- . Ca2+ channel blockers enhance neurotensin (NT) binding and inhibit NT-induced inositol phosphate formation in prostate cancer PC3 cells. J Pharmacol Exp Ther. 2003;307:640–650Erratum: J Pharmacol Exp Ther 2004;309:439
- Signal transduction in c-met mediated motogenesis. EXS. 1993;65:107–130
- Sustained recruitment of phospholipase C-γ to Gab1 is required for HGF-induced branching tubulogenesis. Oncogene. 2000;16:1509–1518
- A role for phospholipase C-γ-mediated signaling in tumor cell invasion. Clin Cancer Res. 1999;5:2251–2260
- . Hepatocyte growth factor-induced differential activation of phospholipase Cγ-1 and phosphatidylinositol 3-kinase is regulated by tyrosine phosphatase SHP-1 in astrocytes. J Biol Chem. 2000;275:31392–31398
- . Hepatocyte growth factor induces activation of Nck and phospholipase C-γ in lung carcinoma cells. Cancer Lett. 1996;12:163–169104
PII: S1078-1439(07)00186-X
doi: 10.1016/j.urolonc.2007.06.003
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 4
, Pages 386-391
, July 2008
